Not applicableLooking for participantsNCT05955859What this trial is testingDiagnostics of Mycotic Sinusitis in ENT PatientsWho this might be right forFungal Sinusitis University Hospital Ostrava 65
Testing effectiveness (Phase 2)Study completedNCT00492089What this trial is testingBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+84 more National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00103259What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Study completedNCT00055913What this trial is testingBevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more National Cancer Institute (NCI) 58
Post-approval studies (Phase 4)Study completedNCT00365508What this trial is testingCounseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingWho this might be right forBladder CancerCervical CancerEsophageal Cancer+8 more Fox Chase Cancer Center 642
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00524017What this trial is testingCetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive TractWho this might be right forHead and Neck CancerPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableLooking for participantsNCT05483374What this trial is testingThe Head and Neck Registry of the European Reference Network on Rare Adult Solid CancersWho this might be right forHead and Neck CancerNasopharynx CancerNasal Cavity and Paranasal Sinus Cancer+2 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13,600
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT00003200What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Study completedNCT03422536What this trial is testingFiclatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Basaloid CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+21 more University of Arizona 78
Testing effectiveness (Phase 2)Study completedNCT05012098What this trial is testingPhase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).Who this might be right forOlfactory NeuroblastomaEsthesioneuroblastomaNeoplasm of the Nasal Cavity National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Not applicableStudy completedNCT00840814What this trial is testingDeveloping a Checklist of Lymphedema Symptoms in Patients With Head and Neck CancerWho this might be right forHead and Neck CancerLymphedema Vanderbilt University 55
Testing effectiveness (Phase 2)Study completedNCT00003264What this trial is testingCisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck CancerWho this might be right forHead and Neck Cancer Fox Chase Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00002506What this trial is testingIsotretinoin Plus Interferon in Treating Patients With Recurrent CancerWho this might be right forCervical CancerEsophageal CancerHead and Neck Cancer+3 more Hoag Memorial Hospital Presbyterian
Early research (Phase 1)Study completedNCT00098943What this trial is testingNGR-TNF in Treating Patients With Advanced Solid TumorsWho this might be right forColorectal CancerHead and Neck CancerKidney Cancer+1 more European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00006361What this trial is testingSU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckWho this might be right forCarcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02535442What this trial is testingNasal Swab Study to Explore the Nasal MicrobiaWho this might be right forCommon Cold Kimberly-Clark Corporation 42